Home
>
National Drug Code (NDC)
>
OPANA
OPANA - 63481-617-70 - (Oxymorphone Hydrochloride)
Drug Information of OPANA
| Product NDC: | 63481-617 |
| Proprietary Name: | OPANA |
| Non Proprietary Name: | Oxymorphone Hydrochloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; Oxymorphone Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of OPANA
| Product NDC: | 63481-617 |
| Labeler Name: | Endo Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021610 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060630 |
Package Information of OPANA
| Package NDC: | 63481-617-70 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63481-617-70) |
NDC Information of OPANA
| NDC Code | 63481-617-70 |
| Proprietary Name | OPANA |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63481-617-70) |
| Product NDC | 63481-617 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxymorphone Hydrochloride |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20060630 |
| Marketing Category Name | NDA |
| Labeler Name | Endo Pharmaceuticals |
| Substance Name | OXYMORPHONE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
